Care Markets

The Orders of St John Care Trust delivered a strong performance for the year to 31 March 2015. There was an overall increase of 8.7%...

Charity Methodist Homes grew steadily during the year to 31 March 2015 with income rising by 2.9% from £174.7m to £179.8m. Operating costs excluding exceptional...

Ahead of selling off 21 of its homes to Orchard Care at the end of last year, the 12-month period to 31st March 2015...

Analysis of health and care funding and expenditure commissioned by County Councils’ Network (CCN), has found that its members have witnessed the largest reductions...

Analysis of Chancellor George Osborne’s reforms for social care funding announced in last years’ Spending Review by The King’s Fund, Nuffield Trust and The...

After the National Living Wage and the postponement of the care cap, social care funding crisis could be further exacerbated by an increasing number...

The Care Quality Commission (CQC) is ‘not yet an effective regulator’ six years after it was established, according to a new report from the...

Almost half of councils are ignoring new rules to protect families from unnecessarily paying top-up fees, according to campaign group Independent Age. It found that...

In its first full year of trading Embrace Group (formerly European Care) reported revenues of £112,433 for the year ended 30 June 2015. After cost of sales of £81.7m and administrative expenses of £25.7m, including an impairment charge of £7.3m, the care home provider made an operating profit of £5.1m. Deducting a £1.7m loss on an unattributed disposal and finance charges and interest, including £6.9m on loan notes, the operator recorded a pre-tax loss of £3.8m. The directors said trading during the report period continued to be challenging’ due to high agency staff costs (particularly due to the impact of nurse shortages), the impact of public sector austerity on occupancy and fees (the latter was on average £671 per week, less than the £721 reported in the three months to 30 June 2014), and more regulation.

The latest figures from the Health and Social Care Information Centre (HSCIC) show that prescriptions for Alzheimer’s drugs are six times higher than a decade ago.